Search research articles
Contact Us
Filters
Showing results (181-190 of 201) with videos related to
Page
of 21
Sort By:
European Journal of Medicinal Chemistry
|
March 14, 2015
Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blasts
Sergio Valente, Veronica Rodriguez, Ciro Mercurio, et al.
ACS Infectious Diseases
|
May 6, 2017
A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors
Marta Esposito, Sára Szadocka, Giulia Degiacomi, et al.
Biorxiv : the Preprint Server for Biology
|
February 9, 2026
The glycine-arginine-rich motif of 53BP1 modulates RNA interactions necessary for its liquid-liquid phase separation during DNA Damage Response
Federica Terraneo, Marta Ceccon, Oscar Sapkota, et al.
Journal of Medicinal Chemistry
|
December 12, 2013
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities
Dante Rotili, Stefano Tomassi, Mariarosaria Conte, et al.
Chemmedchem
|
February 1, 2020
Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation
Rossella Fioravanti, Annalisa Romanelli, Nicola Mautone, et al.
ACS Chemical Neuroscience
|
August 12, 2025
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors
Gabriele Carullo, Ilaria Piano, Giulia Salamone, et al.
Nature Chemical Biology
|
July 4, 2024
Uncoupling histone modification crosstalk by engineering lysine demethylase LSD1
Kwangwoon Lee, Marco Barone, Amanda L Waterbury, et al.
Nature Chemical Biology
|
October 26, 2023
Targeting ROS production through inhibition of NADPH oxidases
Joana Reis, Christoph Gorgulla, Marta Massari, et al.
European Journal of Medicinal Chemistry
|
May 7, 2022
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models
Martina Menna, Francesco Fiorentino, Biagina Marrocco, et al.
Journal of Medicinal Chemistry
|
February 11, 2017
Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 2: Structure-Based Drug Design and Structure-Activity Relationship
Paola Vianello, Luca Sartori, Federica Amigoni, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 201) with videos related to
Sort By:
Page
of 21
European Journal of Medicinal Chemistry
|
March 14, 2015
Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blasts
Sergio Valente, Veronica Rodriguez, Ciro Mercurio, et al.
ACS Infectious Diseases
|
May 6, 2017
A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors
Marta Esposito, Sára Szadocka, Giulia Degiacomi, et al.
Biorxiv : the Preprint Server for Biology
|
February 9, 2026
The glycine-arginine-rich motif of 53BP1 modulates RNA interactions necessary for its liquid-liquid phase separation during DNA Damage Response
Federica Terraneo, Marta Ceccon, Oscar Sapkota, et al.
Journal of Medicinal Chemistry
|
December 12, 2013
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities
Dante Rotili, Stefano Tomassi, Mariarosaria Conte, et al.
Chemmedchem
|
February 1, 2020
Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation
Rossella Fioravanti, Annalisa Romanelli, Nicola Mautone, et al.
ACS Chemical Neuroscience
|
August 12, 2025
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors
Gabriele Carullo, Ilaria Piano, Giulia Salamone, et al.
Nature Chemical Biology
|
July 4, 2024
Uncoupling histone modification crosstalk by engineering lysine demethylase LSD1
Kwangwoon Lee, Marco Barone, Amanda L Waterbury, et al.
Nature Chemical Biology
|
October 26, 2023
Targeting ROS production through inhibition of NADPH oxidases
Joana Reis, Christoph Gorgulla, Marta Massari, et al.
European Journal of Medicinal Chemistry
|
May 7, 2022
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models
Martina Menna, Francesco Fiorentino, Biagina Marrocco, et al.
Journal of Medicinal Chemistry
|
February 11, 2017
Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 2: Structure-Based Drug Design and Structure-Activity Relationship
Paola Vianello, Luca Sartori, Federica Amigoni, et al.
Page
of 21